isoxazoles has been researched along with leptin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Matsui, K; Shibata, T; Wakitani, K; Yonemori, F | 1 |
Jin, Y; Li, J; Lü, XW; Si, HF | 1 |
Guo, A; Jiang, H; Li, J; Lü, X; Si, HF | 1 |
Al-Zaman, Y; Aylwin, S | 1 |
Kim, DW; Park, KS; Yoo, MW | 1 |
Andò, S; Barone, I; Bonofiglio, D; Catalano, S; Gelsomino, L; Giordano, C; Lanzino, M; Malivindi, R; Mauro, L; Panno, ML; Panza, S; Pellegrino, M; Rago, V; Vircillo, V | 1 |
Lee, A; Li, JY; Lu, YX; Owyang, C; Wu, X; Zhou, SY | 1 |
1 review(s) available for isoxazoles and leptin
Article | Year |
---|---|
Emerging concepts in the medical and surgical treatment of obesity.
Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Bariatric Surgery; Body Mass Index; Bupropion; Cholecystokinin; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Fructose; Ghrelin; Humans; Intra-Abdominal Fat; Islet Amyloid Polypeptide; Isoxazoles; Lactones; Leptin; Metabolic Syndrome; Metformin; Obesity; Obesity, Morbid; Orlistat; Oxyntomodulin; Peptide YY; Piperidines; Polycystic Ovary Syndrome; Pyrazoles; Rimonabant; Sertraline; Sleep Apnea, Obstructive; Surgical Procedures, Operative; Topiramate; Zonisamide | 2008 |
6 other study(ies) available for isoxazoles and leptin
Article | Year |
---|---|
JTT-501, a novel oral antidiabetic agent, improves insulin resistance in genetic and non-genetic insulin-resistant models.
Topics: Animals; Blood Glucose; Disease Models, Animal; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Hyperglycemia; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Insulin Resistance; Isoxazoles; Leptin; Lipids; Male; Obesity; Oxidation-Reduction; Phosphorylation; Proteins; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptor, Insulin; Triglycerides | 1998 |
Suppressive effects of leflunomide on leptin-induced collagen I production involved in hepatic stellate cell proliferation.
Topics: Aniline Compounds; Animals; Cell Cycle; Cell Proliferation; Cells, Cultured; Collagen Type I; Crotonates; Culture Media, Conditioned; Cyclin D; Cyclins; Cytokines; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Kupffer Cells; Leflunomide; Leptin; Liver; Macrophage Activation; Nitriles; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; STAT3 Transcription Factor; Toluidines | 2007 |
Suppressive effects of leflunomide on leptin-induced TIMP-1 production involves on hepatic stellate cell proliferation and apoptosis.
Topics: Aniline Compounds; Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Crotonates; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Janus Kinases; Leflunomide; Leptin; Liver; Mitogen-Activated Protein Kinases; Nitriles; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; STAT Transcription Factors; Tissue Inhibitor of Metalloproteinase-1; Toluidines | 2008 |
Low serum leptin level is associated with zonisamide-induced weight loss in overweight female epilepsy patients.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Epilepsy; Female; Follow-Up Studies; Humans; Isoxazoles; Leptin; Linear Models; Middle Aged; Obesity; Prospective Studies; Weight Loss; Young Adult; Zonisamide | 2012 |
Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cancer-Associated Fibroblasts; Carcinogenesis; Cell Communication; Cell Line, Tumor; Culture Media, Conditioned; Female; Gene Expression Regulation, Neoplastic; Humans; Isoxazoles; Leptin; MCF-7 Cells; Mice, Nude; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Suppressor of Cytokine Signaling 3 Protein; Xenograft Model Antitumor Assays | 2016 |
Satiety induced by bile acids is mediated via vagal afferent pathways.
Topics: Afferent Pathways; Animals; Bile Acids and Salts; Deoxycholic Acid; Gene Expression Regulation; Humans; Isoxazoles; Leptin; Neurons; Nodose Ganglion; Rats; Receptor, Cholecystokinin A; Receptors, G-Protein-Coupled; Satiety Response; Vagus Nerve | 2020 |